These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 36275037)

  • 1. Rituximab Dosing in Glomerular Diseases: A Scoping Review.
    Alzayer H; Sebastian KK; O'Shaughnessy MM
    Can J Kidney Health Dis; 2022; 9():20543581221129959. PubMed ID: 36275037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rituximab use in adult glomerulopathies and its rationale.
    Santos JE; Fiel D; Santos R; Vicente R; Aguiar R; Santos I; Amoedo M; Pires C
    J Bras Nefrol; 2020 Mar; 42(1):77-93. PubMed ID: 31904761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases.
    Rovin BH; Adler SG; Barratt J; Bridoux F; Burdge KA; Chan TM; Cook HT; Fervenza FC; Gibson KL; Glassock RJ; Jayne DRW; Jha V; Liew A; Liu ZH; Mejía-Vilet JM; Nester CM; Radhakrishnan J; Rave EM; Reich HN; Ronco P; Sanders JF; Sethi S; Suzuki Y; Tang SCW; Tesar V; Vivarelli M; Wetzels JFM; Lytvyn L; Craig JC; Tunnicliffe DJ; Howell M; Tonelli MA; Cheung M; Earley A; Floege J
    Kidney Int; 2021 Oct; 100(4):753-779. PubMed ID: 34556300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel dosing approach for rituximab in glomerular diseases based on a population pharmacokinetic analysis.
    Hartinger JM; Šíma M; Hrušková Z; Pilková A; Krátký V; Ryšavá R; Jančová E; Bobek D; Douša J; Francová I; Tesař V; Slanař O
    Biomed Pharmacother; 2024 Jun; 175():116655. PubMed ID: 38678967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Rituximab as an Off-Label Medication in Glomerular Diseases: Clinical Perspective.
    AlSahow A; Al-Muhaiteeb A; Nawar H; AlHelal B; AlYousef A; Abdallah E; AbuShall A; Elmekawi S; Meshal B; AlQallaf A; AlRajab H
    Med Princ Pract; 2022; 31(2):133-141. PubMed ID: 35021170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis.
    Jones RB; Ferraro AJ; Chaudhry AN; Brogan P; Salama AD; Smith KG; Savage CO; Jayne DR
    Arthritis Rheum; 2009 Jul; 60(7):2156-68. PubMed ID: 19565480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Instructions and implementations for percutaneous renal biopsy. Guidelines for the therapy of glomerular nephropaties].
    Cagnoli L;
    G Ital Nefrol; 2003; 20 Suppl 24():S3-47. PubMed ID: 14666502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rituximab use in adult primary glomerulopathy: where is the evidence?
    Mallat SG; Itani HS; Abou-Mrad RM; Abou Arkoub R; Tanios BY
    Ther Clin Risk Manag; 2016; 12():1317-27. PubMed ID: 27621641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [State-of-the-art paradigm of corticosteroid therapy for immune-mediated inflammatory kidney diseases].
    Bulanov NM; Bobkova IN; Moiseev SV
    Ter Arkh; 2023 Aug; 95(6):451-456. PubMed ID: 38158962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glomerular Diseases Across Lifespan: Key Differences in Diagnostic and Therapeutic Approaches.
    Windpessl M; Odler B; Bajema IM; Geetha D; Säemann M; Lee JM; Vaglio A; Kronbichler A
    Semin Nephrol; 2023 Jul; 43(4):151435. PubMed ID: 37945450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rituximab in glomerular diseases: a case series and narrative review.
    Duarte I; Oliveira J; Outerelo C; Godinho I; Pereira M; Fernandes P; Jorge S; Gameiro J
    J Bras Nefrol; 2022; 44(2):187-195. PubMed ID: 34874051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab therapy for refractory steroid-resistant nephrotic syndrome in children.
    Kamei K; Ishikura K; Sako M; Ito S; Nozu K; Iijima K
    Pediatr Nephrol; 2020 Jan; 35(1):17-24. PubMed ID: 30564879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rituximab or plasmapheresis for prevention of recurrent focal segmental glomerulosclerosis after kidney transplantation: A systematic review and meta-analysis.
    Boonpheng B; Hansrivijit P; Thongprayoon C; Mao SA; Vaitla PK; Bathini T; Choudhury A; Kaewput W; Mao MA; Cheungpasitporn W
    World J Transplant; 2021 Jul; 11(7):303-319. PubMed ID: 34316454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B cell suppression in primary glomerular disease.
    Rood IM; Hofstra JM; Deegens JK; Wetzels JF
    Adv Chronic Kidney Dis; 2014 Mar; 21(2):166-81. PubMed ID: 24602466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Our experience with rituximab therapy for adult-onset primary glomerulonephritis and review of literature.
    Kong WY; Swaminathan R; Irish A
    Int Urol Nephrol; 2013 Jun; 45(3):795-802. PubMed ID: 22798030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab for Adults With Multi-Drug Resistant Focal Segmental Glomerulosclerosis: A Case Series and Review of the Literature.
    Zhong E; Ghadiri S; Pai A; Marin JG; Barbour SJ
    Can J Kidney Health Dis; 2022; 9():20543581221090010. PubMed ID: 35465258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab-based novel strategies for the treatment of immune-mediated glomerular diseases.
    Kattah AG; Fervenza FC; Roccatello D
    Autoimmun Rev; 2013 Jun; 12(8):854-9. PubMed ID: 23000633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
    Liu ID; Willis NS; Craig JC; Hodson EM
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31749142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remission Induction Therapy with Rituximab for Microscopic Polyangiitis: A Feasibility Study.
    Saito A; Takeuchi Y; Kagaya S; Ojima Y; Fukami H; Sato H; Matsuda K; Nagasawa T
    Tohoku J Exp Med; 2017 May; 242(1):53-62. PubMed ID: 28539536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential Therapy for Remission Induction in Severe Antineutrophil Cytoplasmic Autoantibody-Associated Glomerulonephritis.
    Kant S; Habbach A; Gapud EJ; Manno RL; Gattu R; Seo P; Geetha D
    Am J Nephrol; 2019; 50(5):386-391. PubMed ID: 31593967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.